[Cutaneous administration rather than swallowing].
Schubert-Zsilavecz
Manfred
M
Institut für Pharmazeutische Chemie/ZAFES der Johann Wolfgang Goethe-Universität Frankfurt am Main.
D000279:Administration, Cutaneous; D000368:Aged; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D009122:Muscle Hypertonia / Q000188:drug therapy / Q000451:nursing*; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000188:drug therapy / Q000451:nursing*
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin